DB05516InvestigationalProtein Based Therapies
Pemphigus vulgaris (PV) is an autoimmune disease affecting approximately 40,000 people worldwide. People with PV produce antibodies that attack the cells of the skin, resulting in blisters which, if left... Currently, most doctors who treat patients with PV will prescribe high-dose steroids and drugs that suppress the immune system in an effort to decrease the production of these antibodies.
- Primary indication
- Investigated for use/treatment in autoimmune diseases and skin infections/disorders.Curator reviewed
- Code names
- PI-0824
Resolves to
Compound
What you can answer from here — as of October 05, 2023
Which companies are running trials of PI-0824, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account